Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
2307 search results for:

Prolactinoma 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 08-11-2023 | Prolactinoma | Report

    Aromatase inhibitors as a therapeutic strategy for male prolactinoma resistant to dopamine agonists: a retrospective cohort study and literature review

    Prolactinomas correspond to 40% of all pituitary tumors and almost 70% of them occur in women, usually microadenomas [ 1 ]. In men, on the other hand, macroadenomas are more frequent, not related to a delay in diagnosis, but to a high frequency of …

    Author:
    D. Zúñiga, M. A. M. Stumpf, A. L. S. Monteiro, A. Glezer
    Published in:
    Journal of Endocrinological Investigation > Issue: 5 / 2024
  2. Open Access 01-12-2023 | Prolactinoma | OriginalPaper

    Operative treatment of cystic prolactinomas: a retrospective study

    Prolactinomas represent the most common functional pituitary adenomas (PAs), accounting for approximately 40% of all PAs [ 1 ]. Clinical presentations in prolactinomas patients correlate with either hormonal dysfunction along the …

    Author:
    Weijie Su, Kejun He, Yibing Yang, Jiakun Xu, Xixi Li, Hongxing Tang, Jia Yang, Lixuan Yang
    Published in:
    BMC Endocrine Disorders > Issue: 1 / 2023
  3. 01-12-2023 | Dopamine Agonist | OriginalPaper

    Endoscopic endonasal surgery for prolactinomas: prognostic factors for disease control and management of persistent disease

    Only a limited number of studies have focused on the results of the Endoscopic Endonasal Approach (EEA) for treatment of prolactinomas. We sought to assess the effectiveness of EEA for prolactinoma surgery, identify factors for disease remission …

    Author:
    Aristotelis Kalyvas, Joao Paulo Almeida, Farshad Nassiri, Ruth Lau, Philip J O’Halloran, Nilesh Mohan, Thomas Wälchli, Vincent C. Ye, Dennis M. Tang, Pranay Soni, Tamia Potter, Shereen Ezzat, Varun R. Kshettry, Gelareh Zadeh, Pablo F. Recinos, Fred Gentili
    Published in:
    Neurosurgical Review > Issue: 1 / 2023
  4. Open Access 28-10-2023 | Prolactinoma | Erratum

    Correction: Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?
    Author:
    Victoria R. van Trigt, Ingrid M. Zandbergen, Iris C. M. Pelsma, Leontine E. H. Bakker, Marco J. T. Verstegen, Wouter R. van Furth, Nienke R. Biermasz
    Published in:
    Pituitary > Issue: 6 / 2023
  5. 01-06-2023 | Prolactinoma | OriginalPaper

    MicroRNA-137 inhibits pituitary prolactinoma proliferation by targeting AKT2

    Pituitary adenomas represent intracranial tumors, which approximately counts 10–25%, and they are are now classified as pituitary neuroendocrine tumor (PitNet) according to the fourth edition of the World Health Organization (WHO) Classification …

    Author:
    Q. Xu, Z. X. Yu, Y. L. Xie, L. Bai, S. R. Liang, Q. H. Ji, J. Zhou
    Published in:
    Journal of Endocrinological Investigation > Issue: 6 / 2023
  6. 07-08-2023 | Prolactinoma | ReviewPaper

    Giant prolactinomas, a detailed analysis of 196 adult cases

    Prolactinomas are the most common hormone secreting pituitary tumors, accounting for approximately 40% of all pituitary adenomas, with a prevalence ranging from 25 to 63 per 100,000 people [ 1 , 2 ]. The majority (80%) are microprolactinomas (< 10 …

    Author:
    Billion Lisa, Verleye Arno, De Block Christophe, Van de Heyning Paul, De Herdt Carlien
    Published in:
    Pituitary > Issue: 5 / 2023
  7. 09-11-2022 | Prolactinoma | OriginalPaper

    Metabolic effects of dopamine-agonists treatment among patients with prolactinomas

    Prolactinoma is one of the most prevalent pituitary adenomas affecting about 40% of all pituitary adenoma patients [ 1 ]. It is speculated that high prolactin (PRL) level is associated with the increased risk of cardiovascular morbidity, and …

    Author:
    Maryam Kabootari, Habibeh Shirmohammadli, Fatemeh Golgiri, Seyedarad Mosalamiaghili, Alireza Khajavi, Hamideh Akbari
    Published in:
    Endocrine > Issue: 3 / 2023
  8. Open Access 01-12-2023 | Prolactinoma | OriginalPaper

    Surgery as first-line treatment for prolactinoma? Discussion of the literature and results of a consecutive series of surgically treated patients

    Initial treatment for prolactinoma is usually conservative with dopamine agonists. However, the duration of treatment is often lifelong and can be associated with significant side effects. Surgical outcomes are usually favorable and treatment …

    Author:
    Malte Ottenhausen, Jens Conrad, Lea-Marie Wolters, Florian Ringel
    Published in:
    Neurosurgical Review > Issue: 1 / 2023

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.